New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
The study showed a significant 29% reduction in the risk for heart attack, stroke and death from any cause in the Wegovy users
LHP588 is an oral, brain-penetrant lysine-gingipain (Kgp) inhibitor designed to block the key virulence factor of P. gingivalis
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Subscribe To Our Newsletter & Stay Updated
